|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Research and development expenses | |||||
| General and administrative expenses | |||||
| Operating Loss | |||||
| Operating loss | |||||
| Change in fair value of warrants | |||||
| Finance expenses | |||||
| Finance income | |||||
| Finance income, net | |||||
| Loss for the year from continuing operations | |||||
| Loss for the year | |||||
| Total comprehensive loss attributable to: | |||||
| Owners of the Company | |||||
| Non-controlling interests | |||||
| Other comprehensive loss: | |||||
| Items that will be transferred to profit or loss: | |||||
| Loss (profit) from cash flow hedges | |||||
| Total comprehensive loss for the year | |||||
| Basic loss per ADS - USD (in Dollars per share) | |||||
| Basic loss per Share – USD (in Dollars per share) | |||||
| ADS – USD | |||||
| Total basic loss per Share – USD (in Dollars per share) | |||||
| Diluted loss per Share – USD (in Dollars per share) | |||||
| ADS – USD | |||||
| Total diluted loss per Share – USD (in Dollars per share) | |||||
| Number of ADSs used in calculation (in Shares) | |||||
| Number of Shares used in calculation (in Shares) | |||||
| Loss attributable to: | |||||
| Owners of the Company | |||||
| Non-controlling interests | |||||
Loading...
